TLX.AX vs. REA.AX

Last updated Jun 4, 2026

TLX.AX (Telix Pharmaceuticals Limited) and REA.AX (REA Group Limited) are both stocks. TLX.AX operates in Biotechnology (Healthcare), while REA.AX operates in Internet Content & Information (Communication Services). Over the past 5 years, TLX.AX returned 21.17%/yr vs 0.47%/yr for REA.AX. At a 0.24 correlation, their price movements are largely independent.

Performance

TLX.AX vs. REA.AX - Performance Comparison

The chart below illustrates the hypothetical performance of a A$10,000 investment in Telix Pharmaceuticals Limited (TLX.AX) and REA Group Limited (REA.AX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TLX.AX achieves a 8.93% return, which is significantly higher than REA.AX's -13.03% return.

TLX.AX

• 1D: -3.40%
• 1M: -21.79%
• YTD: 8.93%
• 6M: -14.57%
• 1Y: -53.18%
• 3Y*: 4.08%
• 5Y*: 21.17%
• 10Y*: —

REA.AX

• 1D: 0.20%
• 1M: -9.58%
• YTD: -13.03%
• 6M: -16.11%
• 1Y: -33.49%
• 3Y*: 6.06%
• 5Y*: 0.47%
• 10Y*: 12.29%

*Multi-year figures are annualized to reflect compound growth (CAGR)

TLX.AX vs. REA.AX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TLX.AX Telix Pharmaceuticals Limited	8.93%	-54.49%	144.15%	38.65%	-6.19%	105.03%	143.87%	138.46%	4.84%	-19.48%
REA.AX REA Group Limited	-13.03%	-20.61%	29.99%	65.36%	-33.06%	13.63%	45.18%	41.83%	-2.24%	0.52%

Correlation

The correlation between TLX.AX and REA.AX is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.25
Correlation (3Y) Calculated over the trailing 3-year period	0.29
Correlation (5Y) Calculated over the trailing 5-year period	0.28
Correlation (All Time) Calculated using the full available price history since Nov 16, 2017	0.24

Return for Risk

TLX.AX vs. REA.AX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TLX.AX

TLX.AX Risk / Return Rank: 10
TLX.AX Sharpe Ratio Rank: 6
TLX.AX Sortino Ratio Rank: 6
TLX.AX Omega Ratio Rank: 8
TLX.AX Calmar Ratio Rank: 12
TLX.AX Martin Ratio Rank: 16

REA.AX

REA.AX Risk / Return Rank: 8
REA.AX Sharpe Ratio Rank: 3
REA.AX Sortino Ratio Rank: 5
REA.AX Omega Ratio Rank: 7
REA.AX Calmar Ratio Rank: 12
REA.AX Martin Ratio Rank: 11

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TLX.AX vs. REA.AX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Telix Pharmaceuticals Limited (TLX.AX) and REA Group Limited (REA.AX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TLX.AX	REA.AX	Difference
Sharpe ratio: Return per unit of total volatility	-0.92	-1.08	+0.17
Sortino ratio: Return per unit of downside risk	-1.41	-1.57	+0.15
Omega ratio: Gain probability vs. loss probability	0.83	0.82	+0.01
Calmar ratio: Return relative to maximum drawdown	-0.77	-0.78	0.00
Martin ratio: Return relative to average drawdown	-1.14	-1.29	+0.15
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TLX.AX vs. REA.AX - Sharpe Ratio Comparison

The current TLX.AX Sharpe Ratio is -0.92, which is comparable to the REA.AX Sharpe Ratio of -1.08. The chart below compares the historical Sharpe Ratios of TLX.AX and REA.AX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	TLX.AX	REA.AX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.92	-1.08	+0.17
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.38	0.02	+0.36
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.40	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.66	0.40	+0.26

Drawdowns

TLX.AX vs. REA.AX - Drawdown Comparison

The maximum TLX.AX drawdown since its inception was -72.29%, smaller than the maximum REA.AX drawdown of -96.24%. Use the drawdown chart below to compare losses from any high point for TLX.AX and REA.AX.

Drawdown Indicators

	TLX.AX	REA.AX	Difference
Max Drawdown Largest peak-to-trough decline	-72.29%	-96.24%	+23.95%
Max Drawdown (1Y) Largest decline over 1 year	-68.27%	-42.73%	-25.54%
Max Drawdown (3Y) Largest decline over 3 years	-72.29%	-45.05%	-27.24%
Max Drawdown (5Y) Largest decline over 5 years	-72.29%	-45.80%	-26.49%
Max Drawdown (10Y) Largest decline over 10 years	—	-45.80%	—
Current Drawdown Current decline from peak	-60.82%	-41.53%	-19.29%
Average Drawdown Average peak-to-trough decline	-20.47%	-23.69%	+3.22%
Ulcer Index Depth and duration of drawdowns from previous peaks	44.28%	25.87%	+18.41%

Volatility

TLX.AX vs. REA.AX - Volatility Comparison

Telix Pharmaceuticals Limited (TLX.AX) and REA Group Limited (REA.AX) have volatilities of 10.21% and 10.53%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TLX.AX	REA.AX	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.21%	10.53%	-0.32%
Volatility (6M) Calculated over the trailing 6-month period	40.24%	26.23%	+14.01%
Volatility (1Y) Calculated over the trailing 1-year period	57.76%	30.77%	+26.99%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	56.13%	30.71%	+25.42%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	57.28%	30.60%	+26.68%

Dividends

TLX.AX vs. REA.AX - Dividend Comparison

TLX.AX has not paid dividends to shareholders, while REA.AX's dividend yield for the trailing twelve months is around 1.66%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
REA.AX REA Group Limited	1.66%	1.35%	0.81%	0.87%	1.48%	0.78%	0.74%	1.14%	1.47%	1.19%	1.48%	1.27%
TLX.AX Telix Pharmaceuticals Limited	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both TLX.AX and REA.AX in my portfolio?

TLX.AX and REA.AX have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.